Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:31pm, Monday, 03'rd Aug 2020
Castle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Castle Biosciences (NASDAQ:CSTL) Expected to Announce Earnings of -$0.42 Per Share
05:12am, Monday, 03'rd Aug 2020
Wall Street brokerages forecast that Castle Biosciences (NASDAQ:CSTL) will report earnings per share of ($0.42) for the current quarter, according to Zacks Investment Research. Two analysts have made
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
11:00am, Monday, 27'th Jul 2020
Castle will release its financial results for the second quarter ended June 30, 2020, after the close of market on Monday, August 10, 2020.
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
12:00am, Monday, 27'th Jul 2020
Castle will release its financial results for the second quarter ended June 30, 2020, after the close of market on Monday, August 10, 2020.
Castle Biosciences (NASDAQ:CSTL) Reaches New 12-Month High at $45.27
04:38am, Friday, 17'th Jul 2020
Shares of Castle Biosciences (NASDAQ:CSTL) hit a new 52-week high during trading on Wednesday . The stock traded as high as $45.27 and last traded at $44.28, with a volume of 38331 shares changing han
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 16)
AC Immune SA (NASDAQ: ACIU...
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of a multic
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment deci
Head to Head Analysis: Cancer Genetics (NASDAQ:CGIX) and Castle Biosciences (NASDAQ:CSTL)
01:28am, Tuesday, 14'th Jul 2020
Cancer Genetics (NASDAQ:CGIX) and Castle Biosciences (NASDAQ:CSTL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of the
Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of an indep
What Type Of Shareholders Own The Most Number of Castle Biosciences, Inc. (NASDAQ:CSTL) Shares?
05:39pm, Monday, 06'th Jul 2020
A look at the shareholders of Castle Biosciences, Inc. (NASDAQ:CSTL) can tell us which group is most powerful...
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
09:00pm, Thursday, 02'nd Jul 2020
Castle announced the underwriters have exercised in full their option to purchase an additional 300,000 shares.
Guardant Health (GH) Receives a Buy from Canaccord Genuity - Markets
09:31am, Thursday, 02'nd Jul 2020
In a report released today, Max Masucci from Canaccord Genuity maintained a Buy rating on Guardant Health (GH – Research
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
12:00am, Thursday, 02'nd Jul 2020
Castle announced the underwriters have exercised in full their option to purchase an additional 300,000 shares.
'My husband died from a cancer that is preventable'
05:00am, Wednesday, 01'st Jul 2020
Cliona Murphy lost her husband Brendan to melanoma three years ago. Here, she talks about the difference new treatments made to extending his life, as well as the need for fundraising to continue rese
